DCF — BEAUMONT HEALTH WAYNE
Enterprise Value: $-123.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-123.5M
Enterprise Value
$-42.7M
PV of Cash Flows
$-80.8M
PV of Terminal Value
$-130.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $186.1M | $-5.7M | -3.0% | $-13.6M | $-12.3M |
| Year 2 | $191.7M | $-4.0M | -2.0% | $-12.1M | $-10.0M |
| Year 3 | $197.4M | $-2.1M | -1.0% | $-10.5M | $-7.9M |
| Year 4 | $203.3M | $-1.1M | -1.0% | $-9.8M | $-6.7M |
| Year 5 | $209.4M | $-0.7M | -0.0% | $-9.5M | $-5.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-123.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$180.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.03562919354124939
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5